Patient-derived isolates of the opportunistic pathogen Pseudomonas aeruginosa are frequently resistant to antibiotics due to the presence of sequence variants in resistance-associated genes.
Introduction
As an environmental bacterium, Pseudomonas aeruginosa has been isolated from many different niches including water sources and domestic and health-care settings (1-4). While rarely causing infections in healthy individuals, this opportunistic pathogen can cause a range of infections in people who are immunocompromised or have predisposing conditions such as cystic fibrosis (CF) (1). For adults with CF, P. aeruginosa is the most prevalent bacterium causing respiratory infection and P. aeruginosa from these infections are frequently resistant to antibiotics, complicating treatment (5) . Resistance is associated with variants in key genes that reduce the intracellular concentrations of antibiotics or the affinities of target proteins for antibiotics, relative to antibiotic-susceptible isolates (6). Infection arises from exposure to environmental sources of P. aeruginosa included both the natural and health-care environment (1). Epidemiological studies of isolates obtained from high infection risk areas, such as healthcare settings, domestic and community areas show that antibiotic resistant P. aeruginosa can be present providing a potential reservoir of infectious resistant bacteria (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Acquisition of P. aeruginosa from the natural environment, typically during childhood, is also a major source of infection with a number of studies identifying genotypically indistinguishable strains in the natural environment and the respiratory tract of CF patients (3, (19) (20) (21) (22) . However antibiotic susceptibility of isolates from natural (non-man-made) environmental sources has had very limited studies and so it is not clear whether the natural environment provides a reservoir of antibiotic-resistant P. aeruginosa (7, 23, 24) . Using a cohort of clinical isolates as a comparator, here we determined the prevalence of antibiotic resistance in P. aeruginosa from the natural environment (river), the domestic and community settings (swimming pool and water tank) by assessing antimicrobial susceptibility profiles and allelic variations in resistance genes of P. aeruginosa.
Materials and Methods

Isolate Selection and identification
Fifty environmental P. aeruginosa isolates obtained from water sources in Queensland, Australia and 42 clinical P. aeruginosa isolates obtained from CF patients residing in Australia and New Zealand were examined ( Supplementary Table 1 ). Environmental isolates included those obtained from rivers (n=36), swimming pools (n=13) and one sample from a domestic water tank. Individual multi-locus sequence types (MLST) were present in singleton isolates, expect for sequence types (ST) -155, -179, -266 and -381 which were represented once each in both the CF and environmental isolate cohorts. Isolate identification and MLST typing were confirmed using molecular techniques (https://pubmlst.org/ paeruginosa/) (25) (26) (27) .
Antimicrobial Susceptibility Testing
The minimum inhibitory concentration (MIC) of ciprofloxacin, meropenem, tobramycin and ceftazidime was determined for all the 92 isolates using ETESTÒ strips and methodology. The breakpoint was determined according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (https://clsi.org/).
Resistance Gene analysis
Whole genome sequence assemblies have been described elsewhere (28) Table 2 ). Protein Variation Effect Analyzer (PROVEAN) version 1.1 was utilised to identify and analyse genetic variants within the chosen genes (29) . Genetic variants (amino acid substitutions) were categorised in accordance to PROVEAN scores, as predicted function-altering variants (PROVEAN score: ≤ -2.5) or variants not predicted to affect function (PROVEAN score: > -2.5). Additionally, each genome was manually screened using tblastn for premature stop codons and deletions which were also classified as function-altering variants (30 
Results and Discussion
A total of 50 isolates of P. aeruginosa from the natural environment and 42 isolates from patients with CF were included in this study. The isolates are genetically diverse and broadly representative of the P. aeruginosa species (Supplementary Figure 1) .
Environmental isolates are antibiotic susceptible
All 50 environmental isolates were susceptible to ciprofloxacin, meropenem and tobramycin and only one of these isolates was resistant to ceftazidime (Figure 1, Supplementary Table 3 ).
Conversely (Figure 1 ). Overall our findings are in agreement with a model of bacterial adaptation during infection leading to increased resistance over time (31) . Our results demonstrate that environmental isolates are susceptible to clinically relevant antibiotics and that the environments we tested are not a reservoir for antibiotic resistant isolates.
Environmental isolates have fewer predicted function-altering variants in resistanceassociated genes
We analysed 25 well characterised resistance-associated genes for the presence of likely function-altering variants that could influence antibiotic susceptibility (Supplementary Table   2 ). The environmental isolates had strikingly fewer predicted function-altering variants than the CF isolates. A total of 75 predicted function-altering variants were identified within 18 of 25 resistance genes analysed for the 50 environmental isolates. No predicted function-altering variants were identified in the remaining seven genes (Supplementary Table 3 ). In this cohort, the predicted function-altering variants are generally not sufficient to confer antibiotic resistance as all except one isolate was fully susceptible to the antibiotics tested. In contrast, 110 predicted function-altering variants affecting all 25 resistance-associated genes were identified in the 42 CF isolates. Function-altering variants not analysed by PROVEAN, including premature stop-codons and deletions, were absent in the environmental cohort but were present in nine CF isolates (premature stop-codons n=8, deletions n=2) ( Supplementary   Table 4 ). Overall, variants in the environmental cohort had a significantly higher PROVEAN score than those in the CF cohort (P<0.001), indicating the presence of fewer amino acid substitutions that may affect function of resistance-associated proteins (Supplementary Figure   2 ).
The frequency of function-altering variants within each gene was determined for both cohorts of isolates (Table 1 ). Statistical differences were noted for 6 genes in the CF cohort with a greater number of function-altering variants being present in amgS and fusA1 (tobramycin resistance), gyrA and gyrB (ciprofloxacin resistance) and mexZ (broad-spectrum resistance) genes for isolates in the CF cohort, and in ampE (b-lactam resistance) for the natural environmental isolates (Table 1) . Specific variants present in these genes, such as T83I (gyrA), and R504C (ftsI) previously associated with resistance were only present in the CF isolate cohort only (32, 33) . However, a strong association between individual gene variants and resistance phenotype was not observed ( Supplementary Table 4 ) due to the low numbers of isolates with variants for each gene combined with the multifactorial nature of antibiotic resistance in P. aeruginosa.
ResFinder analysis assessing the presence of horizontally acquired resistance genes identified a gene crpP associated with fluoroquinolone resistance (34) . However there was no correlation between ciprofloxacin resistance and the presence of crpP for the isolates in this study (Supplementary Table 3 and 4). No other horizontally-transferred resistance genes were identified.
In conclusion, our findings show that isolates from P. aeruginosa from natural environments have low frequencies of antibiotic resistance, and of genetic variants associated with resistance, compared to isolates from patients with CF. These findings indicate that the natural environment is unlikely to act as a reservoir of antibiotic-resistant P. aeruginosa. They are consistent with a model in which patients are infected by antibiotic-sensitive P. aeruginosa from the environment which then evolves to become antibiotic-resistant during infection (31) . 
